Available studies (114 found)

Filter citations (author, year, title, ID)
Data type for full-text extraction
Short citationFull citationBioassayEpidemiologyEpi. meta-analysisIn vitroEcology
Anwar, 1994 Anwar WA, Salama SI, el Serafy MM, Hemida SA, and Hafez AS. 1994. Chromosomal aberrations and micronucleus frequency in nurses occupationally exposed to cytotoxic drugs. Mutagenesis 9(4): 315-317. PubMed
Biro, 2011 Biro A, Fodor Z, Major J, and Tompa A. 2011. Immunotoxicity monitoring of hospital staff occupationally exposed to cytostatic drugs. Pathology oncology research : POR 17(2): 301-308. PubMed DOI
Bolognesi, 2005 Bolognesi C, Nucci MC, Colacci AM, Grilli S, Ippoliti F, Mucci N, Romano Spica V, Barbieri A, Canitano N, Chiozzotto D, Di Renzo L, Giordano E, Horn W, Roggieri P, Risi A, Silingardi P, Vaccari M, and Violante FS. 2005. [Biomonitoring of nurses occupationally exposed to antineoplastic drugs: the IMEPA Project]. Epidemiologia e prevenzione 29(5-6 Suppl): 91-95. PubMed
Boughattas, 2010 Boughattas AB, Bouraoui S, Debbabi F, El Ghazel H, Saad A, and Mrizak N. 2010. [Genotoxic risk assessment of nurses handling antineoplastic drugs]. Annales de biologie clinique 68(5): 545-553. PubMed DOI
Bouraoui, 2011 Bouraoui S, Brahem A, Tabka F, Mrizek N, Saad A, and Elghezal H. 2011. Assessment of chromosomal aberrations, micronuclei and proliferation rate index in peripheral lymphocytes from Tunisian nurses handling cytotoxic drugs. Environmental toxicology and pharmacology 31(1): 250-257. PubMed DOI
Bouyer, 1998 Bouyer J et al. Ectopic pregnancy and occupational exposure of hospital personnel. Scand J Work Environ Health 1998; 24 (2):98-103. PubMed
Buono-Michel, 2000 Buono-Michel M, Orsière T, Sari-Minodier I, and Botta A. 2000. Cytogenetic biomonitoring of nurses handling cytostatics. Archives des Maladies Professionnelles et de Medecine du Travail 61(3): 148-155.
Burgaz, 1999 Burgaz S, Karahalil B, Bayrak P, Taskin L, Yavuzaslan F, Bokesoy I, Anzion RB, Bos RP, and Platin N. 1999. Urinary cyclophosphamide excretion and micronuclei frequencies in peripheral lymphocytes and in exfoliated buccal epithelial cells of nurses handling antineoplastics. Mutation research 439(1): 97-104. PubMed
Burgaz, 2002 Burgaz S, Karahalil B, Canhi Z, Terzioglu F, Ancel G, Anzion RB, Bos RP, and Huttner E. 2002. Assessment of genotoxic damage in nurses occupationally exposed to antineoplastics by the analysis of chromosomal aberrations. Human & experimental toxicology 21(3): 129-135. PubMed
Buschini, 2013 Buschini A, Villarini M, Feretti D, Mussi F, Dominici L, Zerbini I, Moretti M, Ceretti E, Bonfiglioli R, Carrieri M, Gelatti U, Rossi C, Monarca S, and Poli P. 2013. Multicentre study for the evaluation of mutagenic/carcinogenic risk in nurses exposed to antineoplastic drugs: assessment of DNA damage. Occupational and environmental medicine 70(11): 789-794. PubMed DOI
Caciari 2012 Caciari T et al. Exposure to antineoplastic drugs in health care and blood chemistry parameters. Clin Ter 2012; 163 (6):e387-92. PubMed
Cavallo, 2005 Cavallo D, Ursini CL, Perniconi B, Francesco AD, Giglio M, Rubino FM, Marinaccio A, and Iavicoli S. 2005. Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees. Mutation research 587(1-2): 45-51. PubMed
Connor, 2010 Connor TH, DeBord DG, Pretty JR, Oliver MS, Roth TS, Lees PS, Krieg EF, Jr., Rogers B, Escalante CP, Toennis CA, Clark JC, Johnson BC, and McDiarmid MA. 2010. Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers. Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 52(10): 1019-1027. PubMed DOI
Cooke, 1991 Cooke J, Williams J, Morgan RJ, Cooke P, and Calvert RT. 1991. Use of cytogenetic methods to determine mutagenic changes in the blood of pharmacy personnel and nurses who handle cytotoxic agents. American journal of hospital pharmacy 48(6): 1199-1205. PubMed
Cornetta, 2008 Cornetta T, Padua L, Testa A, Ievoli E, Festa F, Tranfo G, Baccelliere L, and Cozzi R. 2008. Molecular biomonitoring of a population of nurses handling antineoplastic drugs. Mutation research 638(1-2): 75-82. PubMed
Deng, 2005 Deng HP, Zhang MB, He JL, Wu W, Jin LF, Zheng W, Lou JL, and Wang BH. 2005. Investigating genetic damage in workers occupationally exposed to methotrexate using three genetic end-points. Mutagenesis 20(5): 351-357. PubMed
Deng, 2006 Deng HP, Lou JL, Zhang MB, Wu W, Jin LF, Chen SJ, Zheng W, Wang BH, and He JL. 2006. Detecting the cytogenetic effects in workers occupationally exposed to vincristine with four genetic tests. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis 599(1-2): 152-159. PubMed
Dranitsaris, 2005 Dranitsaris G et al. Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature. J Oncol Pharm Pract 2005; 11 (2):69-78. PubMed
El-Ebiary, 2013 El-Ebiary AA, Abuelfadl AA, and Sarhan NI. 2013. Evaluation of genotoxicity induced by exposure to antineoplastic drugs in lymphocytes of oncology nurses and pharmacists. Journal of applied toxicology : JAT 33(3): 196-201. PubMed DOI
ElShamy 2010 Elshamy K, El-Hadidi M, El-Roby M, and Fouda M. 2010. Health Hazards among Oncology Nurses Exposed to Chemotherapy Drugs. Afr J Haematol Oncol 1(3):70-78.
Ensslin, 1997 Ensslin AS, Huber R, Pethran A, Rommelt H, Schierl R, Kulka U, and Fruhmann G. 1997. Biological monitoring of hospital pharmacy personnel occupationally exposed to cytostatic drugs: urinary excretion and cytogenetics studies. International archives of occupational and environmental health 70(3): 205-208. PubMed
Fransman, 2007 Fransman W et al. Nurses with dermal exposure to antineoplastic drugs: reproductive outcomes. Epidemiology 2007; 18 (1):112-9. PubMed
Garaj-Vrhovac, 1998 Garaj-Vrhovac V, and Kopjar N. 1998. Micronuclei in cytokinesis-blocked lymphocytes as an index of occupational exposure to antineoplastic drugs. Radiology and Oncology 32(4): 385-392.
Grummt, 1993 Grummt T, Grummt HJ, and Schott G. 1993. Chromosomal aberrations in peripheral lymphocytes of nurses and physicians handling antineoplastic drugs. Mutation research 302(1): 19-24. PubMed
Gunnarsdottir, 1997 Gunnarsdottir HK, Aspelund T, Karlsson T, and Rafnsson VV. 1997. Occupational Risk Factors for Breast Cancer among Nurses. International journal of occupational and environmental health 3(4): 254-258. PubMed

Showing studies 1-25 of 114